Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Operating Expenses | 14,114 | 11,360 | 13,543 | 8,548 | 10,579 |
| Operating Income | -14,114 | -11,360 | -13,543 | -8,548 | -10,579 |
| Other Income | 209 | 199 | 137 | -43 | -39 |
| Pre-tax Income | -13,905 | -11,161 | -13,406 | -8,591 | -10,618 |
| Net Income Continuous | -14,027 | -11,161 | -13,406 | -8,591 | -10,618 |
| Net Income | $-14,027 | $-11,161 | $-13,406 | $-8,591 | $-10,618 |
| EPS Basic Total Ops | -16.00 | -12.80 | -16.80 | -12.40 | -73.20 |
| EPS Basic Continuous Ops | -16.11 | -12.75 | -16.84 | -12.48 | -69.76 |
| EPS Diluted Total Ops | -16.00 | -12.80 | -16.80 | -12.40 | -73.20 |
| EPS Diluted Continuous Ops | -16.11 | -12.75 | -16.84 | -12.48 | -69.76 |
| EBITDA(a) | $-14,019 | $-11,285 | $-13,518 | $-8,527 | $-10,521 |